The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology… The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology…

Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research



Rongchai Wang
Nov 07, 2025 11:54

Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions.

Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle.

Advancing Oncology Care

The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer.

Innovative Approaches in Clinical Research

The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms.

Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission.

Data-Driven Health Innovations

By integrating Oracle’s state-of-the-art AI technology with real-world data from Ci4CC’s network of cancer centers, the collaboration aims to transform data into actionable knowledge that can redefine cancer research and improve patient care. This strategic partnership is part of a non-binding agreement, indicating a flexible yet committed approach to achieving their shared objectives.

Image source: Shutterstock

Source: https://blockchain.news/news/oracle-ci4cc-collaborate-enhance-ai-cancer-research

Market Opportunity
Sleepless AI Logo
Sleepless AI Price(AI)
$0.03485
$0.03485$0.03485
-3.94%
USD
Sleepless AI (AI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Unleashing A New Era Of Seller Empowerment

Unleashing A New Era Of Seller Empowerment

The post Unleashing A New Era Of Seller Empowerment appeared on BitcoinEthereumNews.com. Amazon AI Agent: Unleashing A New Era Of Seller Empowerment Skip to content Home AI News Amazon AI Agent: Unleashing a New Era of Seller Empowerment Source: https://bitcoinworld.co.in/amazon-ai-seller-tools/
Share
BitcoinEthereumNews2025/09/18 00:10
CME Group to launch Solana and XRP futures options in October

CME Group to launch Solana and XRP futures options in October

The post CME Group to launch Solana and XRP futures options in October appeared on BitcoinEthereumNews.com. CME Group is preparing to launch options on SOL and XRP futures next month, giving traders new ways to manage exposure to the two assets.  The contracts are set to go live on October 13, pending regulatory approval, and will come in both standard and micro sizes with expiries offered daily, monthly and quarterly. The new listings mark a major step for CME, which first brought bitcoin futures to market in 2017 and added ether contracts in 2021. Solana and XRP futures have quickly gained traction since their debut earlier this year. CME says more than 540,000 Solana contracts (worth about $22.3 billion), and 370,000 XRP contracts (worth $16.2 billion), have already been traded. Both products hit record trading activity and open interest in August. Market makers including Cumberland and FalconX plan to support the new contracts, arguing that institutional investors want hedging tools beyond bitcoin and ether. CME’s move also highlights the growing demand for regulated ways to access a broader set of digital assets. The launch, which still needs the green light from regulators, follows the end of XRP’s years-long legal fight with the US Securities and Exchange Commission. A federal court ruling in 2023 found that institutional sales of XRP violated securities laws, but programmatic exchange sales did not. The case officially closed in August 2025 after Ripple agreed to pay a $125 million fine, removing one of the biggest uncertainties hanging over the token. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/cme-group-solana-xrp-futures
Share
BitcoinEthereumNews2025/09/17 23:55
SEC flags Bitcoin miner hosting services as subject to securities laws

SEC flags Bitcoin miner hosting services as subject to securities laws

                                                                               In a lawsuit, the SEC says some hosted Bitcoin mining services could trigger 
Share
Coinstats2025/12/19 11:23